NEW YORK (GenomeWeb News) – Sigma-Aldrich yesterday reported a 7.4 percent increase in third-quarter sales accompanied by a 14-percent jump in profit for the quarter.
 
For the three months ended Sept. 30, 2008, the company’s sales climbed to $540.6 million from $503.2 million in the comparable period of 2007. Currency effects contributed 3.1 percent, and organic growth was 4.3 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.